Deloitte 2013 global life sciences outlook: Industry adopting new business model to address changing landscape, declining profitThe DTTL report, 2013 global life sciences outlook: Optimism tempered by reality in a “new normal”, concludes that there are several drivers, such as patent expirations, regulatory scrutiny and shifts in innovations are prompting change in the industry.